Fairman Jeff 4
4 · Vaxcyte, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Award
Stock Option (Right to Buy)
2022-12-30+15,000→ 15,000 totalExercise: $47.95Exp: 2032-12-30→ Common Stock (15,000 underlying)
Holdings
- 17,827
Common Stock
- 286,227(indirect: By Trust)
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes 684 shares acquired under the Issuer's Employee Stock Purchase Plan on November 17, 2022.
- [F2]1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.